| |
For 10 million worldwide patients with Parkinson’s disease, news out of Japan that a large pharmaceutical corporation is seeking approval for a new stem cell-based treatment should be hugely encouraging.
Following a successful clinical trial in which seniors between 50 and 59 years of…
|
Click here to view the original article.